Sprint Bioscience
1 known investors
Sprint Bioscience is a pharmaceutical company developing oncology drug candidates aimed at new treatments for hard-to-treat cancers. It uses a fragment-based drug discovery approach and out-licenses its drug programs to global pharmaceutical companies during the preclinical phase.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Sprint Bioscience do?
- Sprint Bioscience is a pharmaceutical company developing oncology drug candidates aimed at new treatments for hard-to-treat cancers. It uses a fragment-based drug discovery approach and out-licenses its drug programs to global pharmaceutical companies during the preclinical phase.
- Who are Sprint Bioscience's investors?
- Sprint Bioscience's investors include First Venture.